Amit M. Oza

University Health Network

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Research Cancer Research professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Summary Precision drug development is focusing on targeting tumor cell surface proteins for therapeutic delivery, maximizing biomarker identified on-target damage to the tumor while minimizing toxicity. A recent article demonstrated high expression of B7-H4 antigen on resistant ovarian cancer cells and described preclinical activity of B7-H4–directed antibody–drug conjugate. See related article by Gitto et al., p. 1567

Year:

2024

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Jessica Lang

Assistant Professor

University of Wisconsin-Madison

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amit M. Oza

Research Interests

Explore related searches

Contact this professor

Articles (7)

Antibody–Drug Conjugates: Advancing from Magic Bullet to Biological Missile

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.

Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events.

Cancer patients' experiences with immune checkpoint modulators: A qualitative study.

Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).

Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.

Collaborators (1)

Jessica Lang

Make your next move.